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VALVE REPLACEMENT ASSOCIATED WITH INCREASED
TRICUSPID REGURGITATION
PAUL NONA, MD

INTRODUCTION
 Transcatheter aortic valve replacement (TAVR) has revolutionized the treatment of aortic stenosis.
 As TAVR procedures increase, more data is available on complications. One such complication is the

development of conduction abnormalities post procedure. Often time conduction abnormalities require
pacemaker placement to maintain cardiac conduction.
 The higher rate of conduction abnormalities post-TAVR represents one of the main limitations of this

treatment approach compared with traditional valve replacement through transthoracic cardiac surgery.
 A common sequelae of pacemaker lead placement is the development of tricuspid regurgitation (TR)

due to wire impingement of leaflet function and coaptation.

PURPOSE
 To quantify long-term sequelae of pacemaker

implantation and its impact on the tricuspid
valve apparatus in patients who underwent
TAVR and subsequently developed
conduction abnormalities requirement
pacemaker implantation.

 To explore the effect of pacemaker

implantation on the development of TR and
parameters of right ventricular (RV) function.

STUDY DESIGN
796 patients underwent TAVR from January 2014 through June 2018

89 patients (11%) underwent pacemaker implantation following TAVR procedure.

34 patients had 2-year follow-up data post-pacemaker implantation and
echocardiographic data obtained and compared.

Echo data
obtained prior to
TAVR

Echo data obtained
between TAVR and PMP

Echo data obtained
after pacemaker

ECHOCARDIOGEAPHIC
VARIABLES
 Ejection Fraction
 Degree of TR
 Pulmonary Artery Pressure
 Tricuspid Annular Plane Systolic Excursion

(TAPSE)
 Degree of Inferior Vena Cava Dilation
 Right Ventricular Diameter (RVD)

PATIENT
DEMOGRAPHICS
Age at TAVR:

79.7 yrs (± 9.0 yrs)

Sex:
Male

19 (56%)

Female

15 (44%)

Race:
Caucasian

30 (88%)

African-American 4 (12%)
BMI:

29 .7 kg/m2 (± 7.0 kg/m2)

Medical Comorbidities:

 Right Ventricle Systolic Pressure

Atrial Fibrillation

 Right Atrium (RA) Area

COPD

11 (32%)

Diabetes

16 (47%)

Hypertension

30 (88%)

CKD

18 (53%)

15 (44%)

RESULTS
Overall, there was a trend towards increased tricuspid
regurgitation severity at two years post-pacemaker
implantation (from 29% to 38% following TAVR and
PMP).



The results additionally indicate a statistically significant
change for the RVD, where the mean RVD increased
from 2.9 cm to 3.5 cm (p-value = 0.039).



While not statistically significant, it should also be noted
that there was an increase in RA size by area evaluation.

Change In TR: Baseline TR to TR after PPM



Change In Tricuspid Severity

CONCLUSION
 Our results demonstrate an increased incidence of worsening

tricuspid regurgitation severity post-TAVR pacemaker implantation.
 Further analysis indicates that in addition to developing worsening

tricuspid regurgitation, there is evidence of early signs of right heart
failure as manifested by increasing RV diameter in select
populations.
 One possible hypothesis is that during TAVR procedure, balloon

inflation for valve anchoring leads to greater expansion of the aortic
annulus and greater risk of injury to Koch triangle during balloon
inflation and deployment.
 Given recent advances in transcatheter tricuspid valve therapies,

more research is required on this complication of TAVR procedure to
better optimize patient selection for transcatheter aortic valve
replacement.
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